Update on evidence for a genetic predisposition to cerebral vasospasm.

Vini G. Khurana, Douglas J. Fox, Irene Meissner, Fredric B. Meyer, Robert F. Spetzler

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Considerable evidence links cerebral vasospasm to the decreased bioavailability of endothelial nitric oxide synthase (eNOS) after aneurysmal subarachnoid hemorrhage (SAH). In recent studies from the cardiology literature, researchers have suggested that a genetic predisposition to coronary vasospasm might develop as the result of a T-786C single nucleotide polymorphism (SNP) in the eNOS gene. The authors of this study attempted to determine if there may be a similar genetic predisposition toward cerebral vasospasm. The authors prospectively identified 28 patients with Fisher Grade 3 SAH from a group of 51 consecutive patients with ruptured intracranial saccular aneurysms. Genomic DNA was isolated from a peripheral blood sample obtained with permission from each patient. Gene microarray technology was used to assay the samples for the presence and distribution of certain key eNOS gene polymorphisms. Clinical, radiological, and genomic data were analyzed. The finding of eNOS T-786C SNP could be used to significantly differentiate between the presence and severity of cerebral vasospasm (p = 0.04). The findings from this preliminary study support similar findings in the coronary vasospasm literature as well as the hypothesis that a predisposition toward cerebral vasospasm may be related partially to genetic factors, which needs to be confirmed in a larger study. Such gene-based information may be important in rapidly identifying patients at increased risk of vasospasm after SAH, independent of their Fisher grade. In this article, the authors review key studies in this area.

Original languageEnglish (US)
JournalNeurosurgical focus [electronic resource].
Volume21
Issue number3
StatePublished - 2006

Fingerprint

Intracranial Vasospasm
Nitric Oxide Synthase Type III
Genetic Predisposition to Disease
Subarachnoid Hemorrhage
Coronary Vasospasm
Genes
Single Nucleotide Polymorphism
Ruptured Aneurysm
Intracranial Aneurysm
Cardiology
Biological Availability
Aneurysm
Research Personnel
Technology
DNA

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Update on evidence for a genetic predisposition to cerebral vasospasm. / Khurana, Vini G.; Fox, Douglas J.; Meissner, Irene; Meyer, Fredric B.; Spetzler, Robert F.

In: Neurosurgical focus [electronic resource]., Vol. 21, No. 3, 2006.

Research output: Contribution to journalReview article

Khurana, Vini G. ; Fox, Douglas J. ; Meissner, Irene ; Meyer, Fredric B. ; Spetzler, Robert F. / Update on evidence for a genetic predisposition to cerebral vasospasm. In: Neurosurgical focus [electronic resource]. 2006 ; Vol. 21, No. 3.
@article{9d8e611f713b44c7b03fada948906ea7,
title = "Update on evidence for a genetic predisposition to cerebral vasospasm.",
abstract = "Considerable evidence links cerebral vasospasm to the decreased bioavailability of endothelial nitric oxide synthase (eNOS) after aneurysmal subarachnoid hemorrhage (SAH). In recent studies from the cardiology literature, researchers have suggested that a genetic predisposition to coronary vasospasm might develop as the result of a T-786C single nucleotide polymorphism (SNP) in the eNOS gene. The authors of this study attempted to determine if there may be a similar genetic predisposition toward cerebral vasospasm. The authors prospectively identified 28 patients with Fisher Grade 3 SAH from a group of 51 consecutive patients with ruptured intracranial saccular aneurysms. Genomic DNA was isolated from a peripheral blood sample obtained with permission from each patient. Gene microarray technology was used to assay the samples for the presence and distribution of certain key eNOS gene polymorphisms. Clinical, radiological, and genomic data were analyzed. The finding of eNOS T-786C SNP could be used to significantly differentiate between the presence and severity of cerebral vasospasm (p = 0.04). The findings from this preliminary study support similar findings in the coronary vasospasm literature as well as the hypothesis that a predisposition toward cerebral vasospasm may be related partially to genetic factors, which needs to be confirmed in a larger study. Such gene-based information may be important in rapidly identifying patients at increased risk of vasospasm after SAH, independent of their Fisher grade. In this article, the authors review key studies in this area.",
author = "Khurana, {Vini G.} and Fox, {Douglas J.} and Irene Meissner and Meyer, {Fredric B.} and Spetzler, {Robert F.}",
year = "2006",
language = "English (US)",
volume = "21",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Update on evidence for a genetic predisposition to cerebral vasospasm.

AU - Khurana, Vini G.

AU - Fox, Douglas J.

AU - Meissner, Irene

AU - Meyer, Fredric B.

AU - Spetzler, Robert F.

PY - 2006

Y1 - 2006

N2 - Considerable evidence links cerebral vasospasm to the decreased bioavailability of endothelial nitric oxide synthase (eNOS) after aneurysmal subarachnoid hemorrhage (SAH). In recent studies from the cardiology literature, researchers have suggested that a genetic predisposition to coronary vasospasm might develop as the result of a T-786C single nucleotide polymorphism (SNP) in the eNOS gene. The authors of this study attempted to determine if there may be a similar genetic predisposition toward cerebral vasospasm. The authors prospectively identified 28 patients with Fisher Grade 3 SAH from a group of 51 consecutive patients with ruptured intracranial saccular aneurysms. Genomic DNA was isolated from a peripheral blood sample obtained with permission from each patient. Gene microarray technology was used to assay the samples for the presence and distribution of certain key eNOS gene polymorphisms. Clinical, radiological, and genomic data were analyzed. The finding of eNOS T-786C SNP could be used to significantly differentiate between the presence and severity of cerebral vasospasm (p = 0.04). The findings from this preliminary study support similar findings in the coronary vasospasm literature as well as the hypothesis that a predisposition toward cerebral vasospasm may be related partially to genetic factors, which needs to be confirmed in a larger study. Such gene-based information may be important in rapidly identifying patients at increased risk of vasospasm after SAH, independent of their Fisher grade. In this article, the authors review key studies in this area.

AB - Considerable evidence links cerebral vasospasm to the decreased bioavailability of endothelial nitric oxide synthase (eNOS) after aneurysmal subarachnoid hemorrhage (SAH). In recent studies from the cardiology literature, researchers have suggested that a genetic predisposition to coronary vasospasm might develop as the result of a T-786C single nucleotide polymorphism (SNP) in the eNOS gene. The authors of this study attempted to determine if there may be a similar genetic predisposition toward cerebral vasospasm. The authors prospectively identified 28 patients with Fisher Grade 3 SAH from a group of 51 consecutive patients with ruptured intracranial saccular aneurysms. Genomic DNA was isolated from a peripheral blood sample obtained with permission from each patient. Gene microarray technology was used to assay the samples for the presence and distribution of certain key eNOS gene polymorphisms. Clinical, radiological, and genomic data were analyzed. The finding of eNOS T-786C SNP could be used to significantly differentiate between the presence and severity of cerebral vasospasm (p = 0.04). The findings from this preliminary study support similar findings in the coronary vasospasm literature as well as the hypothesis that a predisposition toward cerebral vasospasm may be related partially to genetic factors, which needs to be confirmed in a larger study. Such gene-based information may be important in rapidly identifying patients at increased risk of vasospasm after SAH, independent of their Fisher grade. In this article, the authors review key studies in this area.

UR - http://www.scopus.com/inward/record.url?scp=33750576264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750576264&partnerID=8YFLogxK

M3 - Review article

VL - 21

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 3

ER -